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ABSTRACT 
Our study investigated effects of vergence findings on both prepresbyopic 
and presbyopic near spectacle prescriptions. It is possible that individuals with 
inadequate convergence abilities, maintain excessive accommodative effort for 
long periods of time to compensate for the convergence problem. This may 
result in a greater accommodative amplitude than one would expect based on 
age alone. If true, perhaps vision therapy programs utilizing sustained positive 
accommodative techniques, may delay the onset of presbyopia and the need for 
bifocals or reading glasses. 
We hypothesize that 36 - 50 year olds with convergence deficits will have 
larger accommodative amplitudes than an age matched control group. Five 
hundred forty clinic records were sampled from age 36 - 50 from the Pacific 
University Family Vision Facilities between October 25, 1998 and January 26, 
1999. Data from completed vision examinations were collected and analyzed 
using the Statview Analysis Systems. A significant correlation was found 
between age and the add prescription, distance phoria and the add prescription, 
and the fused cross cylinder and the add prescription. No significant correlation 
was found between any of the near vergence findings (Base Out, Base In phoria, 
and NPC) amount of add, however, additional studies are needed to further 
investigate the role distance phoria plays in the amount of add given to patients . 
INTRODUCTION 
We have all heard the phrase "Use it or lose it"; so, can the fact that a 
problem with the vergence system positively affect your ability to 
accommodate? For example, if a person develops convergence insufficiency 
prior to presbyopia, can the constant state of increased accommodation, 
necessary to compensate for vergence, actually prolong the muscle weakening of 
the accommodative system in the adult? 
Of particular interest ts the interaction between phasic and tonic control 
mechanisms with the activity of cross-links between accommodation and 
convergence. These interactions are described by a heuristic model of 
accommodative-vergence interactions that was developed on the basis of several 
laboratory observations .1 
Cross-coupling between accommodation and vergence provides a means of 
dynamically adjusting the tonic set points of the two motor systems to a common 
near or far working distance. Accommodative vergence cross-links play a 
dominant role in coordinating proximal changes in accommodation and 
convergence. The magnitude of cross-link interactions can be modified by 
imbalanced strength of tonic adaptation by accommodation and vergence. 
Reducing adaptation of tonic accommodation increases the AC/ A ratio and 
decreases the CA/C ratio. Reducing adaptation of tonic vergence has the opposite 
effect. 1 
Rouse et al. states that convergence insufficiency consists of exophoria that 
ts greater at near than distance, a remote near point of convergence (NPC), 
decreased positive fusional vergence (PFV), especially for near, and normal 
negative fusional vergence (NFV). 2 One of the earliest descriptions of 
convergence insufficiency as stated by Duane included norms for both distance 
and near as follows: (1) at distance: orthophoria or slight exophoria [2-4 pnsm 
diopters]; normal versions; frequently subnormal abduction [8-1 0 prism 
diopters], not more than 15 prism diopters; and prism convergence often (but 
not always) decreased to 14-20 prism diopters or less; and (2) at nearpoint: 
marked exophoria [12 prism diopters] or greater; normal versions; and a NPC of 
7.5 em or greater.z 
In independent studies, Marg showed that accommodation is under 
autonomic control. 3 Cornsweet and Crane found that voluntary control can be 
attained.4 As a person can remain limber late into life by regular stretching and 
exercismg, perhaps so too can the eye retain more of the flexibility of youth by 
following a certain regimen. 5 If accommodative abilities can be improved m 
prepresbyopic adults as well, it should be possible to delay the onset of 
presbyopia as there will be a larger 'cushion' of surplus ability between normal 
function and presbyopia.s 
The amount of accommodation an individual has at any age IS called the 
amplitude of accommodation. It signified the range of focus (or range of 
accommodation), from infinity to near, that can be used at any time during a 
person's life. The amplitude of accommodation, measured separately for each 
eye, is used to calculate the near add. View Appendix 1 for Table of 
Accommodative Amplitudes.'4 
Presbyopia is considered to be an inevitable part of the agmg process. 
Enoch states that the hallmark of aging of the body is the loss of flexibility.s A 
widely accepted explanation for presbyopia is the loss of flexibility of the lens. 
But, as with the gymnast who, through continued exercise, can remain flexible 
late into life, perhaps with exercise the crystalline lens, too, can retain much of 
its flexibility. The notion that Vision Therapy may improve accommodative 
ability in adults, as was shown in children, is based on the idea that perhaps the 
sensory motor processes of the eye, like skeletal muscle, will benefit from and 
be improved by regular exercise.6 
Previous research which attempted to delay the onset of presbyopia 
concentrated on accommodative facility with techniques designed to rapidly 
move accommodation from distance to near and back. According to Kratka and 
Kratka, the usual routine for convergence insufficiency training consists of (1) 
proximation exercises; (2) prism base-out exercises for near and distance; (3) 
physiological diplopia, framing, bar reading; ( 4) synoptophore; (5) stereoscope 
(at home); and (6) ortho-fusor. 7 
The need for bifocal spectacles, while necessary, is considered undesirable 
by many patients. Some prepresbyopic patients with convergence insufficiency 
over accommodate to maintain fusion. In a retrospective study by Wick, 
subjective complaints were eliminated in 97% of the 161 convergence 
insufficient presbyopic patients between the ages of 45 and 89 years who were 
treated using vision therapy procedures. As well, 92% of the patients improved 
their performance on standard stereopsis and convergence tests.s 
It is possible that individuals with convergence insufficiency, who are 
required to maintain excessive accommodative effort for long periods of time, 
will also maintain a greater accommodative amplitude than will individuals of 
equal age without convergence insufficiency. If true, then vision therapy 
programs could be specifically designed to delay the onset of presbyopia and the 
need for bifocals or reading glasses. We hypothesize that 35-45 year-old 
individuals with convergence deficits will have larger accommodative 
amplitudes than an age-matched control group. 
Drugs That May Cause An Increase m Accommodation 
Cholinergic Agonists 
Anti-Hypertensive Agents 
Agents to treat Deficient Anemias 
Morphine 
Opium 
Stimulants of the Gastrointestinal and Urinary Tracts 
Drugs That May Cause a Loss of Accommodation 
Adjuncts to Anesthesia 
Adrenalcorticosteroids 
Agents to Treat Migrane 
Amebicide Agents 
Anorexiant agents 
Antianxiety agents 
Antibiotics 
Cholingeric Agents 
Anticoagulants 
Anticonvulsants 
Antidepressants 
Antihistimines 
Antihypertensives 
Antimalarial agents 
Antineoplastic agents 
Antiparkinsons agents 
Antispychotic agents 
Antiarrythymic agents 
Antirheumatic agents 
Antispasmodic agents 
Anthelminitic agents 
Antithyroid agents 
Table 1 
** For a detailed listing of specific agents, see list at end of thesis paper. 
RESULTS 
Analysis of the spreadsheet was done with the Statview Analysis Systems. 
The data for all tests can be found at the end of the paper. These consist of a 
raw data table, a drug appendix, and graphs related to selected comparisons. 
The following exam findings were compared to the amount of add prescribed. 
Chi-squared tests were run to establish whether there was a significant 
correlation between the following findings of the add prescribed. (See Table 2) 
• Age 
• NPC Break 
• NPC Recovery 
• Distance Phoria 
• Near Phoria 
• Difference between Distance and Near Phoria 
• Binocular Cross Cylinder Net 
For findings with a significant correlation, two-tailed t-tests were performed 
(see Table 3) . Amounts of add needed for patients with esophoria compared to 
patient exhibiting exophoria with orthophorics included within this population 
was conducted within the first t-test. The second two tailed t-test compared 
esophoric patients to exophoric patients, excluding orthophoric 
patients. See Tables 4 & 5. 
Correlation Coefficient 
Hypothesized Correlation = 0 
Correlation Count Z- Value P-Value 25~ low~r 2~% upper 
Age, Add .579 103 6.616 <.0001 .435 .695 
NPC bk, Add .089 103 0.897 .3695 .1063 .278 
NPC blur, Add .165 103 1.669 .0952 -.029 .348 
Dist. Phoria, Add .252 103 2.579 .0099 .062 .425 
Near Phoria, Add .040 103 .397 .6910 -.155 .231 
Phoria Diff, Add -.138 103 -1.392 .1638 -.323 .057 
FCC Net Add .292 103 3.009 .0026 .105 .460 
Table 2 
Correlation Coefficient 
Hypothesized Correlation = 0 
Correlation Count Z-Value P-Value 25% lgwer 25% upper 
BO Break, Add -0.75 103 -.756 .4499 -.265 -.120 
Add, BO Rec .020 103 .203 .8388 -.174 .213 
Add, BI Break -.033 103 -.331 .7409 -.225 .162 
Add, BI Rec -.054 103 -.538 -.5907 -.245 .141 
Table 3 
Paired T-Tests 
Hypothesized Difference 
Mean Qi:f[ DF I-Valu~ P-Value 
Esoadd, Exoadd .385 51 2.742 .0084 
(exos include orthos) 
Table 4 & 5 
Three of the seven Correlation Coefficient scores showed a P- value 
significance of <0.01. These were Age (p<O.OOl), Distance phoria (p=0.0099), and 
FCC net (p=0.0026). In analyzing the paired t-test, there was noticeable 
increase in significance of P-value when the orthophoric patients were excluded 
in the analysis (p-value from 0.0042 to 0.0015). 
DISCUSSION 
The fact that there was no significant correlation between the power of the 
add and the other vergence findings (NPC break, NPC Blur, Near Phoria, 
Difference in Phoria) may have been due to accommodation not being held 
constant and/or variations in doctor instruction set. 
Possible weaknesses that could have occurred within this study may 
include various environmental factors including different examination lanes, 
lighting conditions, and clarity of projected image of Snellen chart. Other 
variances may have occurred due to the fact that multiple interns, as well as 
advising doctors, performed the examinations. 
In addition, patients could have variables as well including, but not limited to, 
dry eye, seasonal allergies, various systemic conditions, and also sociological and 
psychological conditions possibly affecting the final results. Diurnal variations m 
testing results may also have occurred over the three year span in which our 
queries were selected. Variations in near lenses used in near testing included 
the best spherical binocular visual acuity lens, fused cross cylinder lens, or the 
near subjective lens. 
Ogle believes that proximal convergence makes up for the loss of 
accommodative convergence. It is also been proposed that a presbyopic 
individual has a nearly unrestrained use of accommodative convergence ability. 
The individual can therefore still innervationally try to accommodate, thus 
stimulating accommodative convergence, despite the absence of an 
accommodative response. 9 
Additionally, Hofstetter's study in 1942 showed that proximal convergence 
was effective in bringing about changes in convergence independent of changes 
in accommodation. 10 Morgan in 1950 proposed that proximal convergence is a 
learned function and a part of fusional convergence. 11 
A 1982 study indicated that proximal convergence is of greater relative 
importance in determining the fusion-free position for a presbyopic subject but 
that accommodative convergence is the more important component in 
prepresbyopic subjects. 12 This findings suggests that as accommodative 
convergence diminished with age, the proximal system makes up the difference 
as a learned response. Most investigators would probably agree that (1) an 
extra convergence system does exist, (2) this system operates independently of 
accommodation response, and (3) it is a learned function .I 3 
One treatment modality for patients with convergence insufficiency IS VISIOn 
therapy. These patients are typically treated using the following tests: distance 
screen rocks, binocular lens flips, push-ups, loose lens tromboning, and eye 
stretching activities are just a few of the vision therapy techniques available.s 
Although this was investigated in the Portland Presbyopic Onset Delay Study, we 
were unable to support this due to the lack of patients meeting convergence 
insufficiency protocol in our study. 
The table found in Appendix 1 can be used as a rough estimate, but not as 
an absolute prescribable amount of add. Multiple diagnostic test sequences are 
needed to properly prescribe an adequate add for each individual, such as 
midpoint of positive relative accommodation and negative relative 
accommodation, the near subjective, and fused binocular cross cylinder. 
No significance was found connecting convergence problems with amount 
of add, however, more extensive studies are needed to investigate the role 
distance phoria plays in the amount of add given to patients. 
Conclusion 
As the baby boomer population nears the presbyopic age, the answers to this 
question will become increasingly important as it will affect such a tremendous 
amount of the population. 
Although we were unable to find data to support the hypothesis that 
individuals with convergence difficulties will have larger accommodative 
amplitudes than an age-matched control group, another area of interest 
found may lie in the fact that correlation was found between the distance phoria 
and the amount of add needed by the patient. We feel that these warrant 
further investigation with consistent examination protocols. 
Appendix 114 
Age and Djopters of Accommodation* 
4 years - 15.00D 33 years - 7.75D 
5 years - 14.75D 34 years - 7.50D 
6 years - 14.50D 35 years - 7.25D 
7 years - 14.25D 36 years - 7.00D 
8 years - 14.00D 37 years - 6.75D 
9 years - 13.75D 38 years - 6.50D 
10 years - 13.50D 39 years - 6.25D 
11 years - 13.25D 40 years - 6.00-5.66D 
12 years - 13.00D 41 years - 5.25D 
13 years - 12.75D 42 years - 4.87D 
14 years - 12.50D 43 years - 4.40D 
15 years - 12.25D 44 years - 4.00D 
16 years - 12.00D 45 years - 3.66D 
17 years - 11.75D 46 years - 3.25D 
18 years - 11.50D 47 years - 2.87D 
19 years - 11.25D 48 years - 2.40D 
20 years - ll.OOD 49 years - 2.00D 
21 years - 10.75D 50 years - 1.90D 
22 years - 10.50D 51 years - 1.87D 
23 years - 10.25D 52 years - 1.75D 
24 years - lO.OOD 53 years - 1.66D 
25 years - 9.75D 54 years - 1.50D 
26 years - 9.50D 55 years - 1.40D 
27 years - 9.25D 56 years - 1.33D 
28 years - 9.00D 57 years - 1.25D 
29 years - 8.75D 58 years - l.lOD 
30 years - 8.50D 59 years - l.OOD 
31 years - 8.25D 60 years - l.OOD 
32 years - 8.00D 70 years - O.OOD 
*Calculations made by Nora Nypomnyaschy, COT, Graduate 
of the Boston University School of Medicine 
0 hthalmic Technician Pro ram 
Appendix 215 
Drugs that May Cause an Increase m Accommodation 
Class and Generic Name 
Cholinergic agonist 
Aceclidine* 
Acetylcholine* 
Carbachol* 
Demecarium* 
DFP* 
Echothiophate* 
Isoflurophate* 
Neostigmine* 
Physostigmine* 
Pilocarpine* 
Antihypertensive agent 
Guanethidine 
Agents to treat deficiency anemias 
Methylene blue 
Relief of pain drugs 
Morphine 
Opium 
Stimulants of the gastrointestinal and 
urinary tracts 
Carbachol* 
Increase in Accommodation 
Accommodative Spasm 
Accommodative Spasm 
Accommodative Spasm 
Accommodative Spasm 
Accommodative Spasm 
Accommodative Spasm 
Accommodative Spasm 
Accommodative Spasm 
Accommodative Spasm 
Accommodative Spasm 
Accommodative spasm 
Accommodative spasm 
Accommodative spasm 
Accommodative spasm 
Accommodative spasm 
* These drugs may be used or are principally used in ophthalmic practice. 
Appendix 3 15 
Drugs that May Cause a Loss of Accommodation 
Class and Generic N arne 
Adjuncts to anesthesia 
Methscopolamine 
Scopolamine* 
Adrenal corticosteroids 
Betamethasone* 
Cortisone* 
Dexamethasone* 
Fluorometholone* 
Hydrocortisone* 
Medrysone* 
Prednisolone* 
Agents used to treat deficiency anemias 
Methylene blue 
Agents used to treat m1grame 
Methysergide 
Amebicide agents 
Emetine 
Anorexiant agents 
Amphetamine 
Benzphetamine 
Chlorphentermine 
Dexamphatamine 
Diethylpropion 
Fenfluramine 
Methamphetamine 
Phendimetrazine 
Phenmetrazine 
Phentermine 
Loss of Accommodation 
Decrease/paralysis of accommodation 
Decrease/paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Decrease m accommodation 
Decrease m accommodation 
Paralysis of accommodation 
Decrease In accommodation 
Decrease In accommodation 
Decrease In accommodation 
Decrease In accommodation 
Decrease In accommodation 
Decrease In accommodation 
Decrease In accommodation 
Decrease in accommodation 
Decrease In accommodation 
Decrease In accommodation 
* These drugs are or may be principally used in ophthalmic practice. 
t These have been reported to be side effects, but may not be characteristic of the drug's 
primary action. 
Appendix 3 cont. 
Antianxiety agents 
Carisoprodol 
Chlorodiazepoxide 
Clonazepam 
Diazepam 
Flurazepam 
Lorazepam 
Meprobamate 
Nitrazepam 
Oxazepam 
Prazepam 
Antibiotics 
Benzathine penicillin G 
Chloramphenicol 
Hydrabamine penicillin V 
Nalidixic acid 
Potassium penicillin G 
Potassium penicillin V 
Potasssium phenethicillin 
Procaine penicillin G 
Streptomycin 
Cholineric agonists 
Pilocarpine *t 
Anticoagulants 
Anisidione 
Diphenadione 
Phenindione 
Anticonvulsant agents 
Phenytoin 
Decrease m accommodation 
Decrease m accommodation 
Decrease m accommodation 
Decrease m accommodation 
Decrease m accommodation 
Decrease m accommodation 
Decrease m accommodation 
Decrease m accommodation 
Decrease m accommodation 
Decrease m accommodation 
Decrease m accommodation 
Paralysis m accommodation 
Decrease in accommodation 
Decrease m accommodation 
Decrease m accommodation 
Decrease m accommodation 
Decrease m accommodation 
Decrease m accommodation 
Decrease m accommodation 
Paralysis m accommodation 
Paralysis m accommodation 
Paralysis m accommodation 
Paralysis m accommodation 
Decrease in accommodation 
* These drugs are or may be principally used in ophthalmic practice. 
t These have been reported to be side effects, but may not be characteristic of the drug's 
primary action. 
Appendix 3 cont. 
Antidepressant agents 
Ani tri pty line 
Amoxapine 
Carbamazepine 
Clomipramine 
Desipramine 
Doxepin 
Imipramine 
Nortriptyline 
Protriptyline 
Trimipramine 
Antihypertensive agents 
Mecamylamine 
Pargyline 
Pentolinium 
Tetraethylammonium 
Trimethaphan 
Trimethidini urn 
Antihistamines 
Antozoline* 
Carbinoxamine* 
Clemastine* 
Diphenhydramine* 
Diphenylpyraline * 
Doxylamine* 
Pyrilamine* 
Tripelennamine 
Antimalarial agents 
Amodiaquine 
Chloroquine 
Hydroxychloroquine 
Antineoplatic agents 
Floxuridine 
Fluorouracil 
Procarbazine 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Decrease in accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease in accommodation 
Decrease in accommodation 
Decrease m accommodation 
Decrease in accommodation 
Decrease m accommodation 
Decrease m accommodation 
Decrease m accommodation 
Decrease m accommodation 
* These drugs are or may be principally used in ophthalmic practice. 
Appendix 3 cont. 
Antiparkinsons agents 
Benz tropine 
Biperiden 
Carampiphen 
Chlorphenoxamine 
Procyclidine 
Cycrimine 
Trihexyphenidyl 
Antipsychotic agents 
Acetophenazine 
Butaperazine 
Carphenazine 
Chlorpromazine 
Chlorprothixene 
Diethazine 
Droperidol 
Ethopropazine 
Fluphenazine 
Haloperidol 
Loxapine 
Mesoridazine 
Methidilazine 
Methotrimeprazine 
Perazine 
Periciazine 
Perphenazine 
Piperacetazine 
Prochlorperazine 
Promazine 
Promethazine 
Propiomazine 
Thiopropazate 
Thioproperazine 
Thioridazine 
Thiothixene 
Trifluoperazine 
Trifluperidol 
Triflupromazine 
Trimeprazine 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease in accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease in accommodation 
Decrease in accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease Ill accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Appendix 3 cont. 
Antiarrhythmic agents 
Methachloline 
Antirheumatic agents 
Naproxen 
Antispasmodic agents 
Adiphenine 
Ambutonium 
Anisotropine 
Atropine* 
Belladonna 
Clidinium 
Dicyclomine 
Diphemanil 
Glycopyrrolate 
Hexocyclium 
Homatropine* 
Isopropamine 
Mepenzolate 
Methantheline 
Methixene 
Me thy I atropine nitrate 
Oxyphenonium * 
Oxyphencyclimine 
Pipenzolate 
Piperidiolate 
Poldine 
Propantheline 
Tridehyxethyl 
Anthelmintic agents 
Piperazine 
Antithyroid agents 
Iodide and iodine solution 
and compounds 
Radioactive iodides 
* These drugs are or may be principally used in 
Decrease m accommodation 
Decrease m accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Decrease/Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
Paralysis of accommodation 
ophthalmic practice. 
FEMALES I I I I I IBSBVA 00 I los I I I I I I 
Patient# Date of Birth Date of Exam Age Sex NPCbk NPCbl Sph Cyl Axis · sph Cyl Axis DLPh NLPh Phd iff FCC OD FCC net BObl BObr 
15758 4/21/57 9/8/98 40 F 4 6 -2.00 -0.25 90 -2.00 -0.75 50 -3 -13 -10 -1.25 0.75 18 18 
25518 6/14/57 6/24/97 40 F 0 0 -1.75 -0.25 77 -2.00 0.00 0 -1 -13 12 -0.75 1.00 X 18 
34856 5/1 0/54 1 0/5/9 8 44 F 6 6 0.25 0.00 0 0.50 0.00 0 -1 -12.5 12 2.00 1.75 X 11 
20230 6/8/55 2/6/97 41 F 2 3 0.25 -0.50 170 0.50 0.00 0 0 -11.5 11.5 1.00 0.75 8 20 
15758 4/21/57 9/8/98 41 F 4 6 -2.00 -0.25 90 -2.00 -0.25 50 -3 -11 -8.5 -1.25 0.75 X 18 
23422 3/6/59 2/26/97 37 F 20 30 0.00 -0.50 178 -0.50 -0.75 165 2 -11 12.5 0.75 0.75 8 24 
17880 717157 1 0/2/9 8 41 F 5 7 0.75 0.00 0 0.50 0.00 0 -3 -11 8 2.00 1.2.5 X 18 
24235 3/2/53 4/7/97 44 F 8 10 -0.25 -1.00 90 -0.25 -0.75 85 -4 -10.5 7 1.00 1.25 6 10 
26100 7/30/53 7/8/97 43 F 12 15 -0.50 -0.75 130 -1.00 -0.75 150 -3 -10.5 8 -0.25 0.25 X 24 
29739 11/29/56 1/3/98 42 F 2 6 0.25 -1.00 140 0.75 -1.00 10 2 -9.5 11 0 .50 0 .25 X 10 
33427 4/5/57 8/18/98 41 F 2 3 -3.00 0.00 0 -3.75 0 .00 0 -5 -9 4.5 -2.00 1.00 X 18 
17660 8/23/53 4/19/96 42 F 6 14 0.75 -0.25 180 0.00 0.00 0 1 - 9 10 2.25 1.50 X 12 
139629 12/25/53 9/25/98 44 F 0 5 0.00 0.00 0 0.00 -0.50 20 -2 - 9 -7 1.75 1.75 1 6 16 
22520 10/18/60 1/13/97 36 F 1 5 20 0.25 -0.50 60 0.50 -0.50 105 0 -8 8 0.25 0.00 X 6 
22164 12/13/60 3/2/98 37 F 0 3 -3.50 -0.25 93 -3.50 -1.00 135 0 -8 -8 -4.00 -0.50 8 8 
6147 9/1/56 12/6/94 38 F 0 5 0.25 -1.25 180 0.00 -0.75 180 1 -8 9 2.00 1.75 10 14 
35401 1 0/23/53 1 0/29/98 45 F 0 0 0.00 -0.25 166 0 .00 -0.75 15 1 -8 8.5 1.50 1.50 X 20 
5733 7/5/57 12/9/94 37 F 2 4 -1.25 -0.50 95 -1.50 -0.50 95 -2 -7.5 6 0.50 1.75 X 20 
18386 7/9/54 2/13/97 42 F 4 5 0.00 0.00 0 0.00 0.00 0 -3 -7.5 4.5 0.25 0.25 X 12 
8909 7/2/55 3/30/95 39 F 5 7 0.50 -0.75 90 0.75 -0.50 90 0 -7 7 0.50 0.00 0 12 
17701 6/25/54 4/22/96 41 F 18 25 -0.50 0>00 0 -1.00 0>00 0 2 -7 9 0.50 1.00 X 6 I 
3906 12/13/56 4/2/97 40 F 6 5 -1 .00 0.00 0 -1 ,00 -0.25 115 6 -6.5 12.5 0.00 1.00 X 14 
12926 2/17/57 2/1 9/98 41 F 10 . 10 -0.50 -0.50 95 -0.50 -0.25 99 2 -6.5 8.5 0.25 0.75 X 26 I 
20733 12/26/54 1 0/23/96 41 F 8 25 0.50 0.00 0 0.50 0.00 0 1 -6.5 7.5 1.75 1.25 14 1 6 
6147 9/1/56 7/20/98 41 F 8 8 0.50 -0.25 28 0.25 0.00 0 0 -6 6 1.50 1.00 10 14 i 
13915 6/2/55 "4/23/96 40 F 6 7 0.25 -0.25 75 0.50 -0.50 115 0 -5.5 5.5 1.00 1.25 X 26 i 
34528 2/24/49 1 0/24/98 49 F 5 5 -0.50 0.00 0 0.00 0.00 0 1 -5.5 - 6 1.00 1.50 X 10 
1933 3/17/56 3/28/94 38 F 10 14 0.25 0.00 0 0.50 -0.75 180 1 -4 4.5 1.25 1.00 X 20 
17806 3/26/59 4/22/96 37 F 4 5 0.75 -0.75 165 0.75 -2.00 180 3 -3.5 6 2.00 1.25 6 18 
20955 8/1 6/60 11/7/98 38 F 3 14 0.00 -0.25 5 0.00 -0.25 130 2 -3.5 5 1.00 1.00 X 22 
25153 7/14/57 5/20/97 39 F 3 5 -1.75 -0.75 82 -2.50 0.00 0 -3 -3.5 0.5 -1.75 0.00 X 30 
32631 7/28/58 6/27/98 39 F 6 7 0.25 -0.25 28 0.50 -0.25 160 -3 -3 0.5 0.75 0.50 X 24 
32186 2/16/57 5/29/98 41 F 0 0 0.50 -0.50 10 0.00 -0.50 35 0 -3 3 2.00 1.50 X 30 
20968 4/19/54 10/30/96 42 F 0 0 0.50 0.00 0 0.50 0.00 0 1 -3 4 0.50 0 .00 6 22 
32469 3/17/53 6/9/98 45 F 7 7 1.00 -0.75 165 1.00 -0.50 5 0 -3 3 2.25 1.25 16 18 
24589 7/23/58 4/17/97 38 F 0 1 -3.00 -0.50 135 -2.25 -1.00 20 1 -2.5 3.5 -2.25 0.75 20 24 
17930 9/3/55 5/15/96 40 F 0 0 1.00 -0.25 30 0.50 -0.50 170 3. -2.5 5.5 1.75 0.75 X 18 
5833 9/1 3/55 11/11/94 39 F 3 8 0.50 -1.00 178 0.00 -0.75 3 2 -2 4 1.50 1.00 12 18 
583 6/16/53 11/4/96 • 43 F 5 10 1.25 -0.75 70 1.00 0.00 0 3 -2 4.5 2.25 1.00 8 16 
25955 8/16/58 6/28/97 38 F 0 3 -1.50 -0.75 20 -2. 00 -0.75 170 0 -.0.5 0.5 -0.50 1.00 8 16 
17053 12/11/59 4/2/96 37 F 0 5 -0.75 -0.50 165 -0.75 -0.25 155 6 0 5.5 0.25 1.00 16 16 
19189 12/25/53 7/8/92 38 F 3 6 0.00 0.00 0 0.25 0.00 0 0 0 0 0.25 0.25 6 12 
21091 8/2/57 10/24/96 39 F 8 8 -3.25 -1.00 30 -3.25 -0.75 160 -1 2 3 -3.25 0.00 32 32 
24623 8/29/57 4/17/97 40 F 2 4 -2.50 -1.25 5 -2.75 -0 .50 45 6 2 3 .5 -1.50 1.00 X 16 
27350 6/3/54 9/20/97 43 F 0 0 0.25 0.00 0 0.00 0.00 0 -1 2.5 3.5 1.75 1.50 X 24 
3067 12/25/55 10/29/98 42 F 15 25 -1.00 -0.50 90 0.00 -1.00 95 9 2.5 6.5 0.50 1.50 12 18 
35072 2/12/48 10/9/98 50 F 3.54 10.62 1.25 0 .00 0 1 .75 0 .00 0 1 2.5 1.5 3.25 2.00 12 16 
20667 5/13/58 10/6/96 38 F 3 4 -2.25 0.00 0 -2.25 0.00 0 0 3 3 -0.50 1 .75 18 22 
19595 6/25/58 9/8/98 40 F 2 5 -0.75 0.00 0 -1.25 0.00 0 -3 3 6 -0.25 0 .50 10 14 
13529 5/10/55 11/17/98 43 F 0 5.5 -2.00 -0.50 170 -2.50 -0.75 175 5 3 2 -2.00 0.00 4 10 
32494 1/12/58 6/11/98 40 F 0 0 -0.25 -0.25 105 0.25 -0.50 85 4 8.5 5 0.25 0.50 26 30 
20048 9/2/56 11/10/98 42 F 3 11 -4.00 -0.75 35 -4.25 -1.25 173 14 12 2 -3.75 0.25 0 28 
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12 -24 
-28 -18 -2.75 1 .00 -2.00 -0.25 93 -2.00 -0.25 70 0.75 
12 X 20 16 -3.25 1.25 -2.00 0.00 0 -2.00 0 .00 0 1.00 
6 X 16 12 1.00 3.00 0 .25 0.00 0 0 .50 0.00 0 1.50 
6 X 18 17 -1.25 1.00 0 .75 0.00 0 0 .75 0.00 0 0.00 
12 24 28 18 -2 .75 1.00 -2.00 -0.25 93 -2.00 -0.25 70 0.75 
12 10 12 6 -2.50 1 .50 0.00 -0.50 178 -0 .50 -0.75 165 1.00 
12 X 12 12 0.00 2.50 0 .75 0 .00 0 0 .50 0.00 0 1 .25 
-14 X 26 22 0.50 2 .25 -0.25 -1.00 100 -0 .25 -0.75 85 0 .00 
16 X 30 14 -1.25 1.00 -0.75 -0 .25 130 -1 .25 -0 .25 150 1.00 
-2 X 12 6 -1 .00 2.50 0.25 -1.00 140 0 .75 -1.00 10 0.00 
4 X 22 20 -6 .75 -0.50 -3 .25 0.00 0 -4.00 0.00 0 0.00 
2 X 8 10 1.75 2 .25 2 .25 0 .00 0 1 .50 0 .00 0 0 .00 
24 -18 -20 -22 1.00 2 .50 0 .00 0 .00 0 0 .25 -0 .50 20 1.75 
0 X 18 0 -2.25 1.50 0 .75 -0.50 63 0 .75 -0.50 110 0 .00 
2 -1 8 -18 -14 -6.75 -0.50 -3.50 -0.25 93 -3 .50 -1.00 135 0.00 
-2 12 14 8 -0.25 1.75 0.75 -1.25 180 0.50 -0.75 180 0.00 
0 14 20 18 0.50 2 .75 1 .25 -0.25 166 1 .25 -0.75 15 0.00 
12 X 14 6 -2 .50 2.00 -1 .50 0 .00 0 -1 .50 0 .00 0 0.00 
2 X 14 4 -1 .75 1.75 0 .00 0.00 0 0 .00 0 .00 0 0.00 
4 4 14 12 -0.25 1 .75 0 .50 -0.75 90 0 .75 -0.50 90 0 .00 
4 1 6 20 12 -2.25 2.00 -0.50 0.00 0 -1 .00 0.00 0 0.00 
14 X 14 8 -3.50 2.25 -1.00 0.00 0 -1 .00 -0.25 115 0.00 
24 X 12 10 -0.75 1. 75 -0.50 -0.50 95 -0.50 -0.25 99 0.00 
4 12 18 16 0.00 2.50 0 .25 0.00 0 0.25 0.00 0 1.25 
6 X 10 14 0.75 2 .25 0.50 0 .00 0 0 .50 0 .00 0 1 .25 
18 X 24 18 -0.50 2.25 0.00 0 .00 0 0 .00 0 .00 0 0 .00 
2 X 18 4 0 .50 2.00 -0.50 0 .00 0 0.00 -1.00 90 2.00 
10 8 1 8 8 1.00 2.00 0.75 0.00 0 1 .00 -0.75 150 0.00 
2 12 18 10 -3.25 3.00 0 .50 -0.75 165 0 .50 -1.75 180 0.00 
8 X 14 4 -4.25 2.75 0 .00 -0.25 5 0 .00 -0.25 130 0.00 
18 X 6 4 -4 .00 0 .25 -1 .75 -0.75 82 -2 .50 0 .00 0 0 .00 
12 X 18 12 -0 .75 2 .25 1.00 0 .00 0 1 .00 0 .00 0 0 .00 
6 12 18 12 -0 .50 3.00 0 .50 0 .00 0 0 .50 0.00 0 0 .00 
10 6 12 6 -2.75 3.00 0.25 0.00 0 0.25 0.00 0 1.00 
0 16 18 12 0.50 3.75 1.00 -0.75 165 1 .00 -0.50 5 1.25 
18 X 12 10 -4.75 -0.75 -3.00 -0.50 135 -2.25 -1.00 20 0.00 
10 X 12 6 0.50 3.50 0 .75 -0.25 30 0 .50 -0.50 170 1.00 
14 X 6 2 -0.50 2.75 0 .25 -1.00 180 0 .00 -0.75 180 0 .75 
12 8 1 0 6 0.75 3 .75 1.25 -0.75 70 1.00 0.00 0 1.25 
8 X 16 6 -3 .50 1.75 -1.25 -0.75 13 -2.00 -1.25 175 0.00 
10 12 12 3 -2.00 1.75 -0.75 -0 .50 165 -0.75 -0.25 155 0.00 
5 4 1 0 6 -2.50 2.50 0 .00 0.00 0 0.00 0.00 0 1.00 
30 -18 -18 -18 -6 .50 -0.25 -3.25 -0.75 30 -3.25 -0.75 160 0.00 
4 X 12 4 -3 .25 0 .50 -2.50 -0 .50 150 -2.75 -0.50 45 1.00 
12 6 12 10 0 .25 2.75 0 .50 0 .00 0 0 .50 0 .00 0 0 .00 
0 9 18 12 -1.00 1. 75 -1.00 -0.50 90 0 .00 -1.00 95 1 .00 
12 X 18 6 2.75 4.25 1 .25 0.00 0 1 .75 0.00 0 1.75 
18 X 2 2 -4.25 1.00 -2.00 0.00 0 -2 .00 0.00 0 0.00 
10 16 18 6 -3.50 1.75 -0.75 0.00 0 -1 .00 0.00 0 0.00 
0 6 10 6 -2.25 -1 .25 -2 .50 -1.00 170 -2 .75 -1.00 175 0 .00 
18 X 6 -2 -1 .50 2 .00 -0 .50 0 .00 0 -0 .25 0 .00 0 1 .00 
18 0 8 6 -6 .00 -1.50 -4.00 -0.75 35 -4.25 -1.25 173 2.00 
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23707 11/4/57 3/12/97 39 M 6 16 0.25 0.00 0 0.75 0.00 0 ·2 ·11.5 15.5 1.50 1.25 X 10 ·10 ·18 ·24 
23875 5/7/60 3/13/97 36 M 4 4 ·1.00 ·1.25 105 ·0.50 ·1.50 50 -4 ·14.5 11 0.00 1.00 X 12 6 14 20 
21797 4/6/60 12/5/96 36 M 14 14 0.75 ·0.75 105 0.75 ·1.25 80 0 -12 12 0.50 0.25 X 18 6 10 24 
27269 1/28/54 9115/97 43 M 2 5 -1.75 -0.75 48 -1.25 -0.75 110 ·1 -12 11 ·1.75 o.oo X 5 4 7 18 
20497 11/25/55 10/14/98 42 M 8 30 0.25 -0.50 75 0.25 -0.50 105 -4 ·10 6 1.75 1.50 9 18 9 14 24 
20650 5/19/53 10/23/96 43 M 10 12 -1.00 0 .00 0 -1.00 -1.00 18 0 -10 10 1.00 2.00 X 6 6 X 12 
16379 7/26/56 2119/96 39 M 3 10 -1 .50 o.oo 0 -2.25 0.00 0 0 -9 9 0.25 1.75 X 18 -2 X 20 
18710 11124/55 10/24/98 4 2 M 7 20 -0.25 ·0.50 92 -0.25 ·1.00 92 1 -9 10 1.00 1.25 14 24 ·4 8 22 
21841 5/29/54 11119/96 42 M 10 9 ·0.50 ·0.50 90 -0.50 -1.00 70 1 ·9 10 0.75 1.25 4 6 2 12 20 
24697 6/26/48 10/9/98 50 M 0 0 ·0.50 0.00 0 ·0.25 0.00 0 1 -9 10 1.50 2.00 ,. 18 6 X 18 
1309 11/19/55 9115/94 38 M 8 6 -3.50 0.00 0 ·3.75 -0.50 145 -4 -8.5 5 ·2.00 1.50 X 18 6 X 14 
26198 1113/57 7/26/97 .tO M 16 18 0.25 
-0.25 40 0.00 0.00 180 ·10 ·8.5 1 1.25 1.00 X 18 18 X 10 
95598 2/22/54 4/13/95 41 M 0 0 -0.50 ·0.25 110 ·0.50 -0.25 77 ·2 ·8.5 7 0.25 0 .75 10 I 12 I 6 X 18 
20229 4/8/54 9/30/96 42 M 8 14 0.75 ·2.00 106 0.75 -1.00 73 3 -8 10.5 1.25 0.50 26 38 30 12 24 
20484 8/25/55 9/25/96 41 M 9 11 0 .00 0.00 0 0.00 -0.50 180 3 -7.5 10 1.25 1.25 4 8 4 6 10 ! 
16437 119/54 2/21/96 42 M 2 5 -0.25 ·1.00 85 ·0.75 ·1 .00 85 1 ·7.5 8 1.00 1.25 X 6 2 X 4 ' 
28146 3/25/55 10/25/97 42 M 6 6 0.25 ·0.25 180 0.50 0.00 0 0 ·7.5 7.5 1.75 1.50 X 18 9 X 18 
17644 5/7/56 4119/96 39 M 5 5 ·0.75 -2.00 120 -1.50 -2.50 65 5 ·1 12 ·0.25 0 .50 X 4 0 X 6 
16109 3/8/56 2116/96 39 M 8 8 -4.25 ·0.75 10 ·4.00 -1.00 180 ·3 -7 4 .5 -2.75 1.50 X 4 2 8 14 
20063 8/8/59 9/25/96 36 M 10 5 0.75 ·0.50 180 0.75 0.00 0 ·2 -6.5 5 2.25 1.50 X 12 I ·2 18 24 
20241 8/20/56 9/28/96 40 M 0 6 -2.00 ·0.50 10 -2.25 -0.50 175 -1 -6.5 5.5 1.25 0.75 X 14 I 10 X 10 
20301 3/27/60 1115/97 37 M 2 7 0.25 -0.25 170 3.00 -1.25 67 1 -6 -7 1.75 1.50 6 6 6 -10 -10 
24364 1131153 11/13/98 45 M 1 5 0.50 0 .00 0 0.50 -0.50 90 4 ·6 9.5 2.00 1.50 X 28 16 X 14 
23142 4/7/55 215/97 41 M 0 0 0.50 -0.50 119 0.25 0 .00 0 _, ·5 4 1.50 1.00 X 20 0 X 22 
13758 4/29/55 10/9/95 40 M 6 8 -2.00 ·0.25 5 -2.00 ·0.25 180 3 -4.5 7 0.00 2.00 X 24 2 18 24 
34818 4/1 / 49 10/3/98 49 M 1 5 0.50 0.00 0 0.50 -0.75 140 2 -4 -5.5 3.00 2.50 20 24 10 12 18 
22482 6116/56 1120/97 40 M 3 6 0.50 -0.50 110 0.50 -0.50 95 ·3 -3 0 2.50 2.00 X 14 I 8 12 18 
34431 3/12/55 9/25/98 43 M 1 30 -2.75 0.00 0 -2.50 0 .00 0 0 ·3 -3 ·1.75 1.00 12 12 I ·6 -16 -16 
3120 12119/54 7/21198 4 4 M 5 9 -0.75 ·0.75 20 -1.00 -1.00 165 2 -3 5 0.50 1.25 X 12 I ·2 X 16 
23336 11/5/55 2/15/97 42 M 3 5 2.00 ·0.25 180 1.50 0 .00 0 1 ·3 3.5 3.50 1.50 X 12 10 4 18 
27132 116/56 9119/97 41 M 10 14 0 .50 ·0.25 90 0 .00 0.00 0 1 ·3 3.5 1.25 0.75 x 12 -2 X 18 
4373 1114/53 2/5/98 44 M 15 10 -0.50 ·0.50 105 -0.50 ·1 .00 80 3 ·3 6 0.75 1.25 X 15 0 X 18 
24881 811 9/59 5117/97 37 M 0 4 -2.50 0.00 0 -2.00 0 .00 0 ·3 -2.5 0.5 ·2.00 0.50 X 8 2 X 12 
17571 12110/55 4/24/96 40 M 10 15 -4.00 0 .00 0 -4.25 -1.00 150 2 -2.5 4 -2.75 1.25 X 6 8 12 14 
20945 7/7/59 10118/96 37 M 10 12 0.50 ·0.50 80 0.75 ·0.50 95 2 ·2.5 4 2.25 1.75 X 12 I 2 X 16 
26567 10/24/55 8/2/97 41 M 0 0 0.75 ·0.25 80 0.75 ·0.50 90 0 ·2 2 2.00 1.25 X 12 I 8 8 10 
27535 1115/55 10/7/97 41 M 0 0 · 1.50 ·1.25 165 ·1.50 ·2.00 165 1 ·1 .5 2.5 ·2.50 1.00 X I 18 I 12 6 14 
22961 5/23/53 3/1/97 43 M 0 13 ·0.50 ·0.75 100 -0.75 ·1.00 105 -3 ·0.5 2 .5 1.00 1.50 X 24 I 18 X 24 
22790 10/28/53 8117/98 44 M 0 0 ·2.50 ·1.50 95 ·2.25 ·1.00 95 0 0 0 ·1.25 1.25 X 20 I 16 X 16 
15734 9111/54 1123/96 41 M 15 20 1.00 ·0.25 180 0.25 0.00 0 0 1 1 2.25 1.25 14 18 I 16 X 14 
3917 7110/57 9/15/95 38 M 6 5 1.00 ·0.50 84 1.25 ·0.75 90 2 1.5 0 1.75 0.75 20 24 I 22 X. 8 
27270 6/5/55 9/15/97 42 M 5 7 ·1.50 ·0.75 40 -1.25 -0.50 115 1 1 1.5 9 .5 -0.50 1.00 X 12 6 X 12 
25919 12/6/52 6/28/97 44 M 8 10 ·0.50 o.oo 0 ·0.75 0.00 0 2 2 0 1.00 1.50 X 12 4 X 12 
25520 1/22/56 6110197 41 M 0 0 -1 .50 ·0.25 10 ·2.25 ·0.75 179 0 2.5 2 .5 ·0.50 -1.00 X 6 4 X 8 
29796 4/10/55 1/29/98 42 M 0 0 1.00 ·0.50 50 0.75 ·0.75 165 0 3 3 1.50 0.50 X 32 24 X 24 
19909 11128/52 9/24/96 44 M 14 19 ·4.25 0.00 0 ·3.50 ·0.50 130 1 3 2 -4.25 0 .00 X 20 I 14 X 16 
28932 11/13/55 1212/97 42 M 9 6 -3.12 0.00 0 ·3.25 0.00 0 3 3.5 1 ·1 .75 1.37 X 16 I 14 X 10 
28339 3/26/59 10/30/97 38 M 0 0 -0.25 -0.50 104 ·0.50 ·0.50 31 5 4 1 0.00 ·0.25 16 18 I 10 16 18 
34680 12/4/60 9/26/98 37 M 0 0 ·1.25 0 .00 0 -1.00 0 .00 0 1 4 3 0.25 1.50 16 18 I 14 · 12 ·12 
18067 7/9/55 5/8/96 40 M 0 0 -2.75 ·1.25 75 ·3.75 -1.00 103 4 5 1 ·1 .25 1.50 30 30 12 8 8 
33977 10/20/57 9/8/98 40 M 3 5 -1.25 -0.75 75 -1.25 0 .00 0 ·2 9 11 0.25 1.50 16 30 6 X 24 
22790 10/28/53 2/21194 40 M 0 0 ·2.25 ·2.00 103 ·2.00 ·1.25 103 2 14.5 13 ·1 .00 1.25 X 40 36 X 10 
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·22 ·0.50 1.75 0 .00 0 .00 0 0 .00 0 .00 0 ().00 I 
14 ·5.25 1 .75 -1.50 -1 .25 105 -0.50 -1.50 50 0.00 I 
8 ·2.75 3.50 0 .50 -0 .75 105 0 .50 ·1.25 80 0.00 I 
10 ·3.75 0 .00 ·2.00 ·0.75 48 -1.75 -0.75 110 1.25 I 
14 0.75 2 .75 0 .25 ·0.50 75 0 .25 -0.50 105 1.25 I 
12 -0.50 2.00 ·1.00 0 .00 0 ·1.00 -1.00 18 1.75 I 
12 -3.75 1 .50 -0.75 0 .00 0 ·1.50 0 .00 0 CI.OO 
' 
15 0 .50 2.25 -0.25 -0 .50 92 ·0.25 -1 .00 92 1.25 
12 -0.25 1.50 -0.25 -0.50 90 -0.50 ·1 .00 70 1 .25 
12 0 .50 2.25 -0.50 0 .00 0 -0.25 0 .00 0 1.75 
6 -7.00 ·0.75 ·3.50 0 .00 0 ·3.75 -0.50 145 0.00 
6 -0.75 2 .75 1.00 0 .00 0 1.00 0 .00 0 0.00 
12 ·2.75 2 .75 ·0.50 -0.25 110 ·0.50 ·0.25 77 0 .00 
18 ·0.75 3.25 0 .75 ·2.00 106 0 .75 -1.00 73 0.00 
3 0 .50 2.25 0 .50 0 .00 0 0 .50 0 .00 0 0.75 
4 -0.75 2 .50 -0.25 ·1.00 85 -0.75 -1 .00 85 1.00 
14 -0.25 3.00 0 .00 0 .00 0 0 .25 0.00 0 1.25 
4 -1.75 2.50 ·0.75 -1.75 115 -1 .75 ·1.75 59 0.00 
12 -6.00 ·1.00 -4.25 -0.75 10 -4 .00 ·1.00 180 0 .00 
22 -1.25 4 .00 0 .75 ·0.50 180 0 .75 0.00 0 o.oo 
6 -3.75 ·1.00 -2.00 ·0.50 10 -2.25 -0.50 175 0 .00 
·10 -1.25 2 .25 plano 0 .00 0 2.25 ·1.25 so 1.00 
16 1 .25 I 3 .25 0.50 0 .00 0 0 .50 -0.50 90 1.25 
18 -0.2$ 2 . 50 0 .50 -0.50 119 0.25 0.00 0 o.oo 
12 -2.75 0 .75· ·2.00 ·0.25 5 -2.25 -0.25 180 0 .00 
10 2.00 3 .75 0 .00 0 .00 0 0 .00 0 .00 0 2 .50 
6 -0.75 2.25 1.00 -0.50 110 1.00 -0 .50 95 0 .00 
·8 -2.75 -0.50 ·2.75 0 .00 0 ·2.50 0 .00 0 1.00 
8 -0.50 -1 .25 ·0.75 ·0.75 20 ·1.00 -1.00 165 1.00 
10 1.50 3. 50 1.75 0 .00 0 1.25 0.00 0 1.25 
12 ·0.25 2 .75 0 .50 ·0.25 90 0 .00 0 .00 0 1.50 
0 .0.25 2 .75 -0.25 -0.50 105 ·0.25 -0 .75 80 1.50 
6 -4.75 0.75 -2 .25 0 .00 0 ·2.00 0.00 0 0 .00 
4 ·5.50 -1.75 -4 .00 0 .00 0 -4 .25 ·1.00 150 1.00 
14 -1.00 3.00 0 .50 ·0.50 80 0.75 -0.50 95 1.50 
8 -0.75 2 .25 0 .75 ·0.25 80 0 .75 -0.50 90 o.oo 
10 ·2.25 1.00 ·1.50 ·1.25 165 ·1.50 -2 .00 165 1.00 
18 -2 .25 2 .75 -0.50 -0. 75 100 ·0.75 -1 .00 105 0.00 
10 ·2.25 0 .5 -2.50 ·1 .50 95 ·2.25 ·1 .00 95 1'.50 
6 ·0.75 3.00 0 .75 -0.25 180 0 .00 0 .00 0 0 .00 
6 0 .00 3 .75 0.00 0 .00 0 0 .00 0 .00 0 0.00 
4 ·2.00 1.00 -1 .50 ·0.75 40 · 1.25 ·0.50 115 1.00 
3 · 5.00 2.00 -0.75 0 .00 0 ·0.75 0 .00 0 1.25 
2 -5.00 () .50 · 1.50 -0.25 10 ·2.25 -0.50 179 0.00 
12 0 .50 2 .50 1.00 -0.50 50 0 .75 ·0.75 165 0 .00 
6 ·6.25 ·1 .25 ·4 .25 0 .00 0 -3.50 -0 .50 130 1.00 
6 -4 .75 0 .00 -2 .87 0 .00 0 -3.00 0 .00 0 0 .00 
10 ·2.75 2.00 -0 .25 -0.50 104 -0.25 -0 .50 31 0 .00 
0 ·3.25 1. 25 ·1 .00 0 .00 0 -0.75 0.00 0 0 .75 
6 -3.75 0.25 ·3.00 ·1.25 75 -3.75 ·1 .00 103 0 .00 
16 -2.25 2 .00 -1 .25 -0.75 75 ·1 .25 0 .00 0 0 .00 
4 -2 .25 1.00 ·2.25 ·2.00 103 ·2.00 ·1 .00 105 1.00 
I AvrJ Male Add 0.63 
I 
"' 
!., 
Total Average Add Female Female Male Male Total Average Add 
for Females and Males AvgBORec Avg.Phoria Females Age Males Avg Phoria AvgBORec Age for Females and Ma 
0.00 0.00 -8.00 1 36 3 -11 3.33 36 0 
0.47 7.60 -6.00 5 37 4 -1.75 6.00 37 0.47 
0.10 9.28 -2.20 7 38 3 -1 12.67 38 0.1 
0.08 15.60 -2.70 5 39 4 -10.1 -2.50 39 0.08 
0.42 12.25 -3.38 8 40 8 0.5 12.50 40 0.42 
0.46 8.67 -7.90 9 41 8 -3 6.00 41 0.46 
0.77 5.00 -2.40 6 42 10 -4.6 10.20 42 0.77 
0.78 10.00 -1.75 4 43 4 -6.4 5.50 43 0.78 
1.19 5.33 -10.67 3 44 5 -0.2 6.40 44 1.19 
0.83 0.00 -5.50 2 45 1 -6 16.00 45 0.83 
2.25 2.00 -5.50 1 49 1 -4 10.00 49 2.25 
1.75 12.00 2.50 1 50 1 -9 6.00 50 1.75 
Total Females 52 
Total Males 52 
Total 104 
Page5 
Males Vs. Females 
]c series1 ] 
Total Total Males 
Females 
Female BO Rec Vs. Female Ave 
Phoria 
II Female Avg 80 
Rec 
• Female Avg. 
Phoria 
-2o.oo.u...--------• 
Amount of Add Per Age Group 
2.5 
2 
1.5 
1 
0.5 
o w 1'-
Cl (') 
<t: 
0) ,.... (') 
(') "<t "<t 
1.0 0 
"<t 1.0 
&Total Average 
Add 
• 
Page6 
# of females in each age category 
50 
40 
;~-
0 (') 1.0 1'- 0) 
Male BO Rec Vs. Ave Male Phoria 
20 
1oH---~~._,.~_,~~ 
ow.~~~~~~~~~ 
-1 olll-----tt--------------, 
-2oJ.I--------~ 
II Male Avg Phoria 
• Male Avg 80 Rec 
# of Females and Males in each Age 
Category 
60 
40 
20 
0 llHIIllE II Females • Age DMales 
Fomalo Oisl Pl1ulin Vs. 1\dd 
2.00 • 
1.00 
• • 
1.60 
• 
1.40 
• • • 
1.20 
ADD 
• • • •• • 
0 .80 
•• • 
0.60 
0.40 
0 .20 
1·--·-- • -1- • •·•+ ... wo- • • • + • • • • 
6 
-6 -4 -2 0 2 4 
Distance Phoria 
Male Dlst Phoria Vs. Add 
2 .50 • 
2 .00 
• 
1.50 • • • 
ADD 
• • • • • • 
1.00 • • • • 
• • 
0 .50 
f- •1-------t--•-•-•-• ..,,•o- --•--•·----· • -·- •-
·10 - 5 0 
Distance Phoria 
5 
• 
• 
·- I - I 
8 10 12 14 
• 
1---·---·--
10 15 
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